Dowling-Degos disease 1
MONDO:0024534Any Dowling-Degos disease in which the cause of the disease is a mutation in the KRT5 gene.
Also known as: Dowling-Degos disease 1, Dowling-Degos disease caused by mutation in KRT5, KRT5 Dowling-Degos disease, DDD, DDD1, reticular pigment anomaly of flexures
5 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Hope for rare kidney patients: new drug shows promise in phase 3 trial
Disease control CompletedThis study tested a drug called pegcetacoplan in 124 adults and teens with two rare kidney diseases (C3G and IC-MPGN). The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. Participants received either the drug or a placebo twice a week for 2…
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New serums take on hydroquinone in skin brightening showdown
Symptom relief CompletedThis 4-week pilot study tested two brightening serums against 4% hydroquinone in 18 adults with hyperpigmentation or melasma. Each participant used different products on each side of their face to compare results. The goal was to see if the serums could improve skin tone evenness…
Phase: NA • Sponsor: Revision Skincare • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC